CopyMark Law Group
4.9/5
Drawing for MAPVIEW

USPTO serial 98190510

MAPVIEW

Reviewed by CopyMark Law Group

Reg. 7733678Status 700Registered
Filing date
Status date
Registration date
Mar 18, 2025
Examiner
RENNEKER, CHRISTOPHER JOHN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with MAPVIEW?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jordan A. LaVine

Jordan A. LaVine FLASTER GREENBERG PCSUITE 100, 100 FRONT STREETCONSHOHOCKEN, PA 19428United States

Goods and services

ClassDescriptionStatusFirst use
035Business data collection and analysis services in the field of healthcare, namely, aggregating, organizing and compiling of information, data, statistics, insights, metrics, profiles, analytics and intelligence on healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, care demographics, lab data, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications, all of the foregoing excluding psychedelic medicines and therapies; business consulting and analysis services regarding information, data, statistics, insights, metrics, profiles, analytics and intelligence on healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, care demographics, lab data, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications, all of the foregoing excluding psychedelic medicines and therapies; Providing business information in the field of the healthcare and life sciences industries, all of the foregoing excluding psychedelic medicines and therapies; Business consulting services to businesses in the healthcare and life sciences industries, all of the foregoing excluding psychedelic medicines and therapiesACTIVEMar 19, 2024
042Platform-as-a-service (PaaS) featuring computer software platforms that allows organizations and stakeholders in healthcare viewing of a database with information, data, statistics, insights, metrics, profiles, analytics and intelligence on healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, care demographics, lab data, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications, all of the foregoing excluding psychedelic medicines and therapies; platform-as-a-service (PaaS) featuring computer software platforms that allows organizations and stakeholders in healthcare the ability to model patient journeys, pathways, and care programs, all of the foregoing excluding psychedelic medicines and therapies; computer services, namely, database development services, namely, configuration and customization of databases containing information, data, statistics, insights, metrics, profiles, analytics and intelligence healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, lab data, care demographics, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications, all of the foregoing excluding psychedelic medicines and therapies; platform-as-a-service (paas) featuring computer software platforms that allow the viewing of market access insights to the life sciences industry, provide business solutions that unify pharmaceutical sales, operations, and marketing data, and provide data intelligence that aids with effective targeting, messaging, and initiatives driving sales performance, all of the foregoing excluding psychedelic medicines and therapies; Design, development and implementation of computer software for the healthcare and life sciences industry, namely, the design and development of cloud-based and application-based software for monitoring, marketing, and delivering products in the healthcare and life sciences industry, all of the foregoing excluding psychedelic medicines and therapies; Consulting services in the fields of selection, implementation and use of computer hardware and software systems for others in the health care and life science industries, all of the foregoing excluding psychedelic medicines and therapies; Business technology software consultation services in the health care and life science industries, all of the foregoing excluding psychedelic medicines and therapies; Software development and product development consulting in the field of the health care and life science industries, all of the foregoing excluding psychedelic medicines and therapiesACTIVEMar 19, 2024

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 18, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Mar 18, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 24, 2025SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Feb 24, 2025CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Feb 21, 2025SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Feb 21, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 11, 2024IUAFUSE AMENDMENT FILED—
Dec 11, 2024EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Aug 20, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 25, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 25, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 5, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 22, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 22, 2024XAECEXAMINER'S AMENDMENT ENTERED—
May 22, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 22, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
May 22, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
May 14, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 14, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 14, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 14, 2024DOCKASSIGNED TO EXAMINER—
Nov 1, 2023TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Nov 1, 2023PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Oct 8, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 25, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance